CMRA (Comera Life Sciences Holdings) Common Stock: $0.00 Mil (As of Sep. 2023)


What is Comera Life Sciences Holdings Common Stock?

Comera Life Sciences Holdings CMRA Common Stock is $0.00 Mil as of Sep. 2023.

Comera Life Sciences Holdings's quarterly common stock stayed the same from Mar. 2023 ($0.00 Mil) to Jun. 2023 ($0.00 Mil) but then increased from Jun. 2023 ($0.00 Mil) to Sep. 2023 ($0.00 Mil).

Comera Life Sciences Holdings's annual common stock declined from Dec. 2020 ($10.68 Mil) to Dec. 2021 ($0.00 Mil) but then increased from Dec. 2021 ($0.00 Mil) to Dec. 2022 ($0.00 Mil).

Comera Life Sciences Holdings Common Stock Historical Data

* Premium members only.

The historical data trend for Comera Life Sciences Holdings's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Comera Life Sciences Holdings Common Stock Chart

Comera Life Sciences Holdings Annual Data
Trend Dec20 Dec21 Dec22
Common Stock
10.68 0.00 0.00

Comera Life Sciences Holdings Quarterly Data
Dec20 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Comera Life Sciences Holdings Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Frequently Asked Questions Learn more about Common Stock →
What does a Common Stock of $0.00 Mil mean?
Comera Life Sciences Holdings (CMRA) has a Common Stock of $0.00 Mil as of Sep. 2023. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Comera Life Sciences Holdings and its competitors.
Is Comera Life Sciences Holdings' Common Stock too high?
Comera Life Sciences Holdings' current Common Stock is $0.00 Mil.
How does Comera Life Sciences Holdings' Common Stock compare to FREQ and BNTC?
Comera Life Sciences Holdings' Common Stock of $0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for a Biotechnology company?
A good Common Stock depends on the Biotechnology industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Comera Life Sciences Holdings and its competitors. Comera Life Sciences Holdings's current Common Stock is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Comera Life Sciences Holdings stock overvalued right now?
Comera Life Sciences Holdings (CMRA) has a current Common Stock of $0.00 Mil. The current Common Stock is $0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For Comera Life Sciences Holdings (CMRA), the current Common Stock is $0.00 Mil as of Sep. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Comera Life Sciences Holdings Business Description

Address 12 Gill Street, Suite 4650, Woburn, MA, USA, 01801
Comera Life Sciences Holdings Inc is a pre-clinical biotechnology company dedicated to promoting formulation science and technology to transform essential biologic medicines from intravenous to subcutaneous forms. Comera's internal portfolio of proprietary techniques known as the SQore platform is designed to potentially transform essential biologic medicines from intravenous (IV) to subcutaneous (SQ) forms, and optimize current versions of subcutaneous biologics, and produce biosimilar versions of existing subcutaneous products. It also collaborates with pharmaceutical and biotechnology companies, applying the SQore platform to the Company's partners' biologic medicines to deliver enhanced formulations that facilitate self-injectable care.